Patrick Machado, 10% Owner at Urovant Sciences Ltd. (UROV), bought 8,285 shares at $7.98 ($66K) on 2019-05-20, disclosed to the SEC on 2019-05-20.
Open-market purchase of $66k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-06-19 | $56K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-19 | $55K | — | Filing → |